Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mrna and its responsive genes in fructose-fed, ovariectomized rats

Journal of Nutrition

Volumn 139, Issue 4, 2009, Pages 640-645

  Shrestha, Sudeep ^a   Ehlers, Sarah J ^b   Lee, Ji Young ^b   Fernandez, Maria Luz ^a   Koo, Sung I ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; CHOLESTEROL; FATTY ACID SYNTHASE; FRUCTOSE; GLUCOSE; GREEN TEA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; SCAVENGER RECEPTOR BI; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID TRANSPORT; LIPOGENESIS; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANIMAL FOOD; CHEMISTRY; COLOR; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; ORGAN SIZE; SPRAGUE DAWLEY RAT; TEA;

RATTUS; ZEA MAYS;

ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; COLOR; FEMALE; FRUCTOSE; GENE EXPRESSION REGULATION; LIVER; ORGAN SIZE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TEA; TRIGLYCERIDES;

EID: 64049094508     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.103341     Document Type: Article

References (44)

1. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr. 2007;26:S373-88.
2. Crespy V, Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 2004;134:S3431-40.
3. Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D. Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr Cancer. 2003;45:226-35.
4. Chan PT, Fong WP, Cheung YL, Huang Y, Ho WKK, Chen ZY. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr. 1999;129:1094-101.
5. Yang M, Wang C, Chen HL. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem. 2001;12:14-20.
6. Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem. 2005;16:144-9.
7. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr. 2005;81:S317-25.
8. Löest HB, Noh SK, Koo SI. Green tea extract lowers the lymphatic absorption of cholesterol and α-tocopherol in ovariectomized rats. J Nutr. 2002;132:1282-8.
9. Wang S, Noh SK, Koo S. I. Epigallocatechin gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats. J Nutr. 2006;136:2791-6.
10. Wang S, Noh SK, Koo SI. Green tea catechins inhibit pancreatic phospholipase A2 and intestinal absorption of lipids in ovariectomized rats. J Nutr Biochem. 2006;17:492-8.
11. Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Bio- chem. 2007;18:179-83.
12. Shishikura Y, Khokhar S, Murray BS. Effect of tea polyphenols on emulsification of olive oil in a small intestine model system. J Agric Food Chem. 2006;54:1906-13.
13. Moon HS, Lee HG, Choi YJ, Kim TG, Cho CS. Proposed mechanisms of (-)- epigallocatechin-3-gallate for anti-obesity. Chem Biol Interact. 2007;167:85-98.
14. Lin JK, Lin-Shiau SY. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res. 2006;50:211-7.
15. Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Mol Nutr Food Res. 2006;50:188-210.
16. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, Weber P. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. 2006;136:2512-8.
17. Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab. 2005; 49:54-63.
18. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab. 2005;2:5.
19. Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart J-C, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis. 1995;118:123-33.
20. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
21. Reeves PG. AIN-93 purified diets for the study of trace element metabolism in rodents. In: Watson RR, editor. Trace elements in laboratory rodents. Boca Raton (FL): CRC Press; 1996. p. 3-37.
22. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5.
23. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantification of high-density lipoprotein cholesteol. Clin Chem. 1982;28:1379-88.
24. Carr TP, Andresen CJ, Rudel LL. Enzymatic determination of triglyc- erides, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem. 1993;26:39-42.
25. Reljic R, Ries M, Anić N, Ries B. New chromogen for assay of glucose in serum. Clin Chem. 1992;38:522-5.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-8.
27. SAS Institute, Inc. SAS user's guide: statistics, version 5. Cary (NC): SAS Institute; 1985. p. 433-506.
28. Rutledge AC, Adeli K. Fructose and the metabolic syndrome: patho- physiology and molecular mechanisms. Nutr Rev. 2007;65:S13-23.
29. Miyazaki M, Dobrzyn A, Man WC, Chu K, Sampath H, Kim HJ, Ntambi JM. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem. 2004;279:25164-71.
30. Matsuzaka T, Shimano H, Yahagi N, Amemiya-Kudo M, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Tomita S, et al. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes. 2004;53:560-9.
31. Bruno RS, Dugan CE, Smyth JA, DiNatale DA, Koo SI. Green tea extract protects leptin-deficient spontaneously obese mice from hepatic steatosis and injury. J Nutr. 2008;138:323-31.
32. Busserolles J, Mazur A, Gueux E, Rock E, Rayssiguier Y. Metabolic syndrome in the rat: females are protected against the pro-oxidant effect of a high sucrose diet. Exp Biol Med (Maywood). 2002;227:837-42.
33. Galipeau D, Verma S, McNeill JH. Female rats are protected against fructose-induced changes in metabolism and blood pressure. Am J Physiol Heart Circ Physiol. 2002;283:H2478-84.
34. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404-11.
35. Huang BW, Chiang MT, Yao HT, Chiang W. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab. 2004;6:120-6.
36. Oram JF, Vaughan AM. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006;99:1031-43.
37. Klaus S, Pültz S, Thóne-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet- induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond). 2005;29:615-23.
38. Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol. 2006;26:1702-11.
39. Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA. Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol. 2007;18:310-8.
40. Temel RE, Lee RG, Kelley KL, Davis MA, Shah R, Sawyer JK, Wilson MD, Rudel LL. Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2. J Lipid Res. 2005;46: 2423-31.
41. Davidson NO, Shelness GS. Apolipoprotein B: mRNA editing, lipo- protein assembly, and presecretory degradation. Annu Rev Nutr. 2000; 20:169-93.
42. Kaul D, Sikand K, Shukla AR. Effect of green tea polyphenols on the genes with atherosclerotic potential. Phytother Res. 2004;18:177-9.
43. Kuhn DJ, Burns AC, Kazi A, Dou QP. Direct inhibition of the ubiquitin- proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression ofsterolregulatoryelement-binding protein 2 and LDL receptor. Biochim Biophys Acta. 2004;1682:1-10.
44. Bursill CA, Roach PD. Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells. J Agric Food Chem. 2006;54:1621-6.